Follow
Nahid Sultana
Nahid Sultana
University of the Pacific
Verified email at u.pacific.edu
Title
Cited by
Cited by
Year
Molecular targeting of RRM2, NF-κB, and Mutant TP53 for the treatment of triple-negative breast cancer
EA Wilson, N Sultana, KN Shah, HL Elford, JS Faridi
Molecular Cancer Therapeutics 20 (4), 655-664, 2021
122021
RRM2 and mutant p53 as therapeutic targets in TNBC
N Sultana, EA Wilson, HL Elford, JS Faridi
Cancer Research 81 (13_Supplement), 1240-1240, 2021
2021
The benefits of Didox in triple negative breast cancer treatment targeting mutant p53
N Sultana, EA Wilson, KN Shah, HL Elford, JS Faridi
Cancer Research 80 (16_Supplement), 5212-5212, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–3